Home » Two Sites Pull Out of Trials for GSK’s Avandia
Two Sites Pull Out of Trials for GSK’s Avandia
GlaxoSmithKline and some physicians are having trouble recruiting patients for a large clinical trial of its controversial diabetes drug Avandia.
newsobserver
newsobserver
Upcoming Events
-
07May
-
14May
-
30May